There are 2867 resources available
CN84 - Anaemia & iron deficiency in oncology & haemato-oncology patients undergoing systemic anti-cancer therapy
Presenter: Elizabeth Flanagan
Session: Poster session 19
Resources:
Abstract
CN85 - Use of chamomile liposomal gel to prevent moist desquamation in breast cancer patients
Presenter: Amanda Menêses
Session: Poster session 19
Resources:
Abstract
CN86 - Experiences of everyday life and self during outpatient cancer treatment and care: A qualitative study
Presenter: Tina Siersbaek
Session: Poster session 19
Resources:
Abstract
CN87 - Pre-surgery demographic, clinical, and symptom characteristics associated with different self-reported cognitive processes in patients with breast cancer
Presenter: Yu-Yin Allemann-Su
Session: Poster session 19
Resources:
Abstract
133O - Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial
Presenter: Vivianne Tjan-Heijnen
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
451O - Preliminary evidence of clinical activity from phase I and Ib trials of the CLK/DYRK inhibitor cirtuvivint (CIRT) in subjects with advanced solid tumors
Presenter: Aaron Scott
Session: Proffered Paper session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
1482O - A phase III study comparing methotrexate (M), adriamycin (A) and cisplatin (P) with MAP + ifosfamide (MAP + IF) for the treatment of osteosarcoma: JCOG0905
Presenter: Hiroaki Hiraga
Session: Proffered Paper session: Sarcoma
Resources:
Abstract
Slides
Webcast
655MO - Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy (RT) with either cisplatin or cetuximab in NRG/RTOG 1016
Presenter: Jolie Ringash
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
LBA66 - IMmotion010: Efficacy and safety from the phase III study of atezolizumab (atezo) vs placebo (pbo) as adjuvant therapy in patients with renal cell carcinoma (RCC) at increased risk of recurrence after resection
Presenter: Axel Bex
Session: Proffered Paper session 1: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Update on diagnosis: Novel concepts of WHO
Presenter: Pieter Wesseling
Session: Insight the new CNS WHO classification: Novel concepts and therapeutic implications for gliomas
Resources:
Slides
Webcast